| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/13/2002 | EP1185674A1 Cationic lipids for gene transfer and preparation method thereof |
| 03/13/2002 | EP1185618A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185553A1 Heart homing peptides and methods of using same |
| 03/13/2002 | EP1185551A1 Method for purification of proteins |
| 03/13/2002 | EP1185502A1 Polyhydroxy diamine surfactants and their use in gene transfer |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP1185309A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 03/13/2002 | EP1185307A2 Methods of imaging and targeting tumor vasculature |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185305A1 Ligand-conjugated oligomeric compounds |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185301A1 Emulsion vehicle for poorly soluble drugs |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185288A1 Hemoactive compositions and methods for their manufacture and use |
| 03/13/2002 | EP1185273A1 Antifungal oral composition containing itraconazole and process for preparing same |
| 03/13/2002 | EP1185254A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 03/13/2002 | EP1185252A1 Novel formulations comprising lipid-regulating agents |
| 03/13/2002 | EP1185251A1 A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same |
| 03/13/2002 | EP1185249A2 Methods and compositions for treating solid tumors |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP1185246A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
| 03/13/2002 | EP1185171A1 Compositions and methods comprising morphine gluconate |
| 03/13/2002 | EP0717638B1 Cyclodextrins for the reduction of extravasation toxicity caused by cytotoxic compounds |
| 03/13/2002 | EP0652757B1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
| 03/13/2002 | CN1340102A Polypeptide variants with raised heparin-binding capacity |
| 03/13/2002 | CN1340079A Freeze-dried agent containing paramylon, production and utilization thereof |
| 03/13/2002 | CN1340057A Synthetic poly peptide disturbing intracelluler signaling |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339969A Liposone composition and method for administration of a radiosensitizer |
| 03/13/2002 | CN1339965A Combinations of formoterol and fluticasone propionate for asthma |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339962A Stable non-aqueous single phase viscons vehicles and formulations utilizing such vehicles |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339944A Organoprotective solutions |
| 03/13/2002 | CN1339321A Transdermal administration enhancer capable of being degraded and absorbed biologically |
| 03/13/2002 | CN1339297A New medicine release system-liposolubility medicinal preparation |
| 03/13/2002 | CN1080575C Conjugation-stablized polypeptide compositions, therapeutic delivery and disgnostic formulations comprising same, and method of making and using the same |
| 03/13/2002 | CN1080562C Use of prostance derivatives and the combination with antibiotics in the treatment of bacterial infections |
| 03/13/2002 | CN1080561C Anti-inflammatory agent for external use |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355752 Water soluble and swellable; cosmetic thickeners |
| 03/12/2002 | US6355693 Solvent extraction; mixing with alcohol; desolventizing |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355657 Loperamide hydrochloride in propylene carbonate and ethanol |
| 03/12/2002 | US6355611 Salt form of a conjugate useful in the treatment of prostate cancer |
| 03/12/2002 | US6355609 Methods for stabilizing liquid nutritional products and products so stabilized |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355276 Adhesive drug delivery composition |
| 03/12/2002 | US6355274 Encapsulated long chain alcohols |
| 03/12/2002 | US6355273 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 03/12/2002 | US6355272 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharamaceutical compositions |
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355268 Liposome-entrapped topoisomerase inhibitors |
| 03/12/2002 | US6355266 Indomethacin-containing patch; for theray of pain due to contusion, sprain or muscular fatigue, and pain associated with shoulder stiffness |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355243 Method of thrombolysis by local delivery of active plasmin |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355198 Method of forming articles including waveguides via capillary micromolding and microtransfer molding |
| 03/12/2002 | CA2347330C Liquid injectable formulation of disodium pamidronate |
| 03/12/2002 | CA2313783C Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof |
| 03/12/2002 | CA2047944C Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/12/2002 | CA2032581C Hydrolytically degradable hydrophilic gels and the method for preparation thereof |
| 03/11/2002 | CA2357055A1 Carotenoid esters |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018477A2 Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
| 03/07/2002 | WO2002018450A1 New cross-linked derivatives of hyaluronic acid |
| 03/07/2002 | WO2002018448A2 Percarboxylated polysaccharides, and a process for their preparation |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002017983A1 Medicinal compositions for forming tissue around bone or tooth, process for preparing the same, injections for forming tissue around bone or tooth and process for preparing the same |
| 03/07/2002 | WO2002017967A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | WO2002017962A2 Chemoprotectant for gastric toxicity |
| 03/07/2002 | WO2002017956A2 Stabilized fgf formulations containing reducing agents |
| 03/07/2002 | WO2002017939A1 A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra |
| 03/07/2002 | WO2002017932A1 Oct preparations |
| 03/07/2002 | WO2002017927A1 Method for treating erectile dysfunction and increasing libido in men |
| 03/07/2002 | WO2002017926A1 Pharmaceutical composition and method for treating hypogonadism |
| 03/07/2002 | WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | WO2002017921A2 Paroxetine compositions and processes for making the same |
| 03/07/2002 | WO2002017918A2 Sustained release formulations for growth hormone secretagogues |
| 03/07/2002 | WO2002017892A2 Water-dispersible encapsulated sterols |
| 03/07/2002 | WO2002017889A1 Transdermal therapeutic system for releasing venlafaxine |
| 03/07/2002 | WO2002017888A2 Controlled and sustained release properties of polyelectrolyte multilayer capsules |
| 03/07/2002 | WO2002017887A1 Medicament for treating intestinal diseases |
| 03/07/2002 | WO2002017886A1 Pectin film compositions |
| 03/07/2002 | WO2002017883A2 Milled particles |
| 03/07/2002 | WO2002017881A2 Transdermal pharmaceutical delivery composition |
| 03/07/2002 | WO2002017880A2 Nitric oxide-producing hydrogel materials |
| 03/07/2002 | WO2002017878A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | WO2002017855A2 Process for preparing pharmaceutical compositions for use with soft gelatin formulations |